Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years

BACKGROUND: The emergence of immune-escape variants of severe acute respiratory syndrome coronavirus 2 warrants the use of sequence-adapted vaccines to provide protection against coronavirus disease 2019. METHODS: In an ongoing phase 3 trial, adults older than 55 years who had previously received th...

Descripción completa

Detalles Bibliográficos
Autores principales: Winokur, Patricia, Gayed, Juleen, Fitz-Patrick, David, Thomas, Stephen J., Diya, Oyeniyi, Lockhart, Stephen, Xu, Xia, Zhang, Ying, Bangad, Vishva, Schwartz, Howard I., Denham, Douglas, Cardona, Jose F., Usdan, Lisa, Ginis, John, Mensa, Federico J., Zou, Jing, Xie, Xuping, Shi, Pei-Yong, Lu, Claire, Buitrago, Sandra, Scully, Ingrid L., Cooper, David, Koury, Kenneth, Jansen, Kathrin U., Türeci, Özlem, Şahin, Uğur, Swanson, Kena A., Gruber, William C., Kitchin, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933930/
https://www.ncbi.nlm.nih.gov/pubmed/36652353
http://dx.doi.org/10.1056/NEJMoa2213082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933930/
https://www.ncbi.nlm.nih.gov/pubmed/36652353
http://dx.doi.org/10.1056/NEJMoa2213082

Ejemplares similares